Dietary Restriction Delays But Cannot Heal Irradiation-Induced Hair Graying by Preserving Hair Follicle Stem Cells in Quiescence.

aging dietary restriction hair cycle hair graying

Journal

Rejuvenation research
ISSN: 1557-8577
Titre abrégé: Rejuvenation Res
Pays: United States
ID NLM: 101213381

Informations de publication

Date de publication:
29 Nov 2023
Historique:
pubmed: 7 11 2023
medline: 7 11 2023
entrez: 7 11 2023
Statut: aheadofprint

Résumé

DNA damage represents one of the cell intrinsic causes of stem cell aging, which leads to differentiation-induced removal of damaged stem cells in skin and blood. Dietary restriction (DR) retards aging across various species, including several strains of laboratory mice. Whether, DR has the potential to ameliorate DNA damage-driven stem cell exhaustion remains incompletely understood. In this study, we show that DR strongly extends the time to hair graying in response to γ-irradiation (ionizing radiation [IR])-induced DNA damage of C57BL/6 J mice. The study shows that DR prolongs resting phase of hair follicles. DR-mediated prolongation of hair follicle stem cell (HFSC) quiescence blocks hair growth and prevents the depletion of HFSCs and ckit

Identifiants

pubmed: 37933912
doi: 10.1089/rej.2023.0037
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Rongrong Qiu (R)

Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.
Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.

Xingxing Qiu (X)

Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.
Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.

Mingyue Su (M)

Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.
Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.

Man Sun (M)

Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.
Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.

Yiting Wang (Y)

Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.

Jianying Wu (J)

Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.
Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.

Hua Wang (H)

Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.
Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.

Duozhuang Tang (D)

Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.

Si Tao (S)

Jiangxi Key Laboratory of Clinical and Translational Cancer Research, Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.
Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang City, China.

Classifications MeSH